Antifungal prophylaxis in critically ill patients

doi:10.1186/cc6906

Critical Care

Volume 12
Issue 3

Viewing options:

Abstract
Full text
PDF (34KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Silvestri L
Zandstra DF
van Saene HK
Petros AJ
Thyagarajan S
de la Cal MA
Thomann C

on PubMed

Silvestri L
Zandstra DF
van Saene HK
Petros AJ
Thyagarajan S
de la Cal MA
Thomann C
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Letter

Antifungal prophylaxis in critically ill patients

Luciano Silvestri¹ , Durk F Zandstra², Hendrick KF van Saene³, Andy J Petros⁴, Sujatha Thyagarajan⁵, Miguel A de la Cal⁶ and Corrado Thomann¹

¹Department of Emergency, Unit of Anaesthesia and Intensive Care, Presidio Ospedaliero, Via Vittorio Veneto 171, 34170 Gorizia, Italy

²Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Oosterpark 9, 1091 AC Amsterdam, The Netherlands

³Department of Medical Microbiology, University of Liverpool, Duncan Building, Daulby Street, Liverpool L69 3GA, UK

⁴Paediatric and Neonatal Intensive Care Unit, Great Ormond Street Children's Hospital, Great Ormond Street, London WC1N 3JH, UK

⁵Department of Intensive Care, Alder Hey Children's Hospital, Eaton Road, Liverpool L12 2AP, UK

⁶Intensive Care Unit, University Hospital, Carretera de Toledo km 12,500, 28905 Getafe, Madrid, Spain

author email corresponding author email

Critical Care 2008, 12:420doi:10.1186/cc6906


Published:	13 June 2008

See related research by van Till et al., http://ccforum.com/content/11/6/R126

First paragraph (this article has no abstract)

We congratulate van Till and colleagues on their review showing that selective decontamination of the digestive tract (SDD) is more effective than single-drug prophylaxis (SAP) in reducing yeast colonisation, infection and mortality [1].